ProfileGDS4718 / 228810_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 89% 84% 57% 83% 90% 70% 58% 85% 77% 86% 91% 87% 68% 65% 71% 80% 83% 72% 66% 42% 92% 92% 87% 89% 88% 60% 85% 32% 84% 70% 72% 61% 84% 92% 49% 66% 77% 85% 82% 47% 82% 57% 62% 77% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.0212489
GSM549102patient 115, normal, homogenized [OPG study]8.3147184
GSM549104patient 119, normal, homogenized [OPG study]5.9277557
GSM549108patient 138, normal, homogenized [OPG study]8.0683283
GSM549119patient 077, normal, homogenized [OPG study]9.1828690
GSM549133patient 032, cancer, homogenized [OPG study]6.9394870
GSM549139patient 042, cancer, homogenized [OPG study]5.9518658
GSM549099patient 107, normal, homogenized [OPG study]8.3971285
GSM549109patient 139, normal, homogenized [OPG study]7.5057177
GSM549110patient 046, normal, homogenized [OPG study]8.5513686
GSM549114patient 063, normal, homogenized [OPG study]9.5737891
GSM549122patient 082, normal, homogenized [OPG study]8.7659387
GSM549134patient 033, cancer, homogenized [OPG study]6.6917868
GSM549136patient 036, cancer, homogenized [OPG study]6.4712965
GSM549140patient 044, cancer, homogenized [OPG study]7.0431871
GSM549111patient 047, normal, homogenized [OPG study]7.888180
GSM549113patient 057, normal, homogenized [OPG study]8.281783
GSM549132patient 031, cancer, homogenized [OPG study]7.074972
GSM549137patient 038, cancer, homogenized [OPG study]6.5481766
GSM549142patient 047, cancer, homogenized [OPG study]5.2155642
GSM549100patient 110, normal, homogenized [OPG study]9.4546492
GSM549107patient 135, normal, homogenized [OPG study]9.7241992
GSM549115patient 068, normal, homogenized [OPG study]8.8822887
GSM549116patient 072, normal, homogenized [OPG study]9.1294189
GSM549120patient 078, normal, homogenized [OPG study]8.9125188
GSM549131patient 030, cancer, homogenized [OPG study]6.1363460
GSM549118patient 074, normal, homogenized [OPG study]8.543985
GSM549129patient 027, cancer, homogenized [OPG study]4.6281532
GSM549123patient 088, normal, homogenized [OPG study]8.2949384
GSM549124patient 006, cancer, homogenized [OPG study]6.7986270
GSM549126patient 015, cancer, homogenized [OPG study]7.0666172
GSM549128patient 025, cancer, homogenized [OPG study]6.2446361
GSM549103patient 117, normal, homogenized [OPG study]8.1606784
GSM549117patient 073, normal, homogenized [OPG study]9.7863792
GSM549138patient 041, cancer, homogenized [OPG study]5.4708549
GSM549141patient 045, cancer, homogenized [OPG study]6.6051466
GSM549130patient 028, cancer, homogenized [OPG study]7.4593477
GSM549101patient 111, normal, homogenized [OPG study]8.3863285
GSM549105patient 128, normal, homogenized [OPG study]8.044782
GSM549106patient 134, normal, homogenized [OPG study]5.2998347
GSM549112patient 048, normal, homogenized [OPG study]8.1016382
GSM549125patient 011, cancer, homogenized [OPG study]5.9561557
GSM549127patient 024, cancer, homogenized [OPG study]6.2968262
GSM549135patient 035, cancer, homogenized [OPG study]7.5867477